ArticleJournal of cancer science and clinical therapeutics2021

Wild-Type TP53 Predicts Poor Prognosis in Patients with Gastric Cancer.

Wenhong Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.